pH7
PrivateLast Round
Grant
Jun 30, 2026
Total Funding Raised
$56.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
pH7 is a digital health company that provides a platform connecting patients with medical cannabis specialists for consultations, digital prescriptions, and home delivery services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Workflow Automation, Pharma Supply Chain, Compliance
Business Model
B2B2C
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pH7 Comparables
Compare pH7 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nugg | 78% | |
| Releaf Dispensary Ltd | 74% | |
| Organigram Global Inc. | 74% |
pH7 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 30, 2026 | ||||
| Debt | Mar 1, 2026 | ||||
| Grant | Dec 4, 2025 | ||||
| Series B | Dec 4, 2025 | ||||
| Series A | Mar 27, 2023 | ||||
Grant | Dec 9, 2021 |
pH7 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fine Structure Ventures | Series B |
| Sustainable Development Technology Canada | Grant |
| Gaingels | Series B |
| Rhapsody Venture Partners | Series A, Series B |
| SiteGround Capital | Series B |
| Collaborative Fund | Series A |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Secured $4M in grant funding from Natural Resources Canada.
- Apr 16, 2026
Monthly visitors increased 235% MoM, reaching 1.6K.
pH7 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about pH7's valuation, stock price, and market status.
Is pH7 a public or private company?
pH7 is a private company.
What is the current stock price of pH7?
pH7 is a private company with no public stock price. Caplight tracks pH7's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is pH7 worth (valuation)?
Valuation information for pH7 is not publicly available.
Can I buy pH7 stock?
pH7 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was pH7's last funding round?
pH7's most recent funding round was Grant on June 30, 2026.
Who are the main investors in pH7?
Key investors in pH7 include Fine Structure Ventures, TDK Ventures, Pangaea Ventures.
Will pH7 IPO soon?
No public IPO plans have been announced for pH7.
How can I track pH7 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor pH7's secondary market activity and sign up for updates.